首页> 外文期刊>American Journal of PharmTech Research >RP-HPLC Method Development and validation for estimation of sumatriptan and naproxen in spiked human plasma
【24h】

RP-HPLC Method Development and validation for estimation of sumatriptan and naproxen in spiked human plasma

机译:RP-HPLC方法开发和估算加标人血浆中舒马曲坦和萘普生的验证

获取原文
           

摘要

ABSTRACT A rapid, simple, selective, and specific reverse phase high performance liquid chromatography (RP-HPLC) method was developed and validated for estimation of Naproxen and Sumatriptan from tablet using spiked human plasma. The chromatographic separation was performed on Phenomenex Luna C18 column (5μm, 25cmx4.6mm id)  with a mobile phase comprised of Acetonitrile: Methanol: phosphate buffer pH 6 (50:10:40 v/v), at a flow rate of 1.0ml/min. The calibration curve was linear in the range of 1-3 µg/ml. The developed method was found to accurate and sensitive. Results of recovery studies prove the extraction efficiency. Stability data indicated that Sumatriptan and Naproxen was stable in plasma after three freeze thaw cycles and upon storage at −20°C for 30 days. Keywords: Sumatriptan, Naproxen, Human Plasma, RP-HPLC
机译:摘要建立了快速,简单,选择性和特异的反相高效液相色谱(RP-HPLC)方法,并验证了使用加标人体血浆从片剂中估计萘普生和舒马普坦的有效性。色谱分离在Phenomenex Luna C18色谱柱(5μm,25cmx4.6mm内径)上进行,流动相由乙腈:甲醇:磷酸盐缓冲液pH 6(50:10:40 v / v)组成,流速为1.0ml /分钟。校准曲线在1-3 µg / ml范围内是线性的。发现所开发的方法准确且灵敏。回收研究的结果证明了提取效率。稳定性数据表明,舒马曲坦和萘普生在三个冻融循环后和在-20°C下储存30天后在血浆中稳定。关键词:舒马曲坦,萘普生,人血浆,RP-HPLC

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号